Alnylam Pharmaceuticals, Inc. (ALNY)
Publicly reported company facts and saved market data for Alnylam Pharmaceuticals, Inc. (ALNY), with sources and as-of times. Saved data is not a live quote.
Company profile
Alnylam (Nasdaq: ALNY) is a leading global biopharmaceutical company and the pioneer of the RNA interference (RNAi) revolution. The Company is focused on developing transformative therapies with the potential to prevent, halt, or reverse disease. For more than two decades, Alnylam has advanced the Nobel-Prize-winning science of RNAi, delivering critical breakthroughs and six approved medicines. Alnylam has medicines available in more than 70 countries and a rapidly expanding and robust pipeline, in addition to consistently being recognized as an exceptional workplace and socially responsible organization. The Company is executing on its Alnylam 2030 strategy to accelerate innovation and scale impact to transform human health.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $22.1B · as of
- Incorporated in
- Unavailable
- Company website
- www.alnylam.com
- Exchange
- NASDAQ
Saved quote
Saved snapshot, not a real-time quote. Check the market time before relying on it.
- Last reported price
- $165.88
- Reported change
- -4.67%
- Reported volume
- 7,056,813
- Latest market time
Float and shares outstanding
| Measure | Shares | As of | Source and basis |
|---|---|---|---|
| Float | 133,608,403 | Reported by a single source; not cross-checked. | |
| Shares outstanding (O/S) | 133,809,118 | SEC 10-Q filing · filed |
Dates are measurement dates, not the time FennEdge retrieved the data. Float references are listed separately; they are not averaged or adjusted for later splits or share issuances.
Short interest
- Reported short interest
- 6,568,786 shares
- Settlement date
- Source
- Market and company data
Exchange-published short interest for the stated settlement date, not a live short position.
Recent daily sessions
The 10 most recent saved daily sessions, through . Daily OHLC and volume; not real-time.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| 222.72 | 232.88 | 220.00 | 232.40 | 1,944,031 | |
| 225.00 | 228.49 | 222.82 | 226.79 | 1,603,484 | |
| 226.24 | 232.48 | 224.10 | 227.66 | 1,436,998 | |
| 227.28 | 229.39 | 222.00 | 224.03 | 1,055,960 | |
| 224.92 | 229.82 | 223.76 | 227.28 | 2,212,201 | |
| 227.86 | 230.84 | 224.88 | 225.10 | 1,181,021 | |
| 237.73 | 238.96 | 229.54 | 230.71 | 1,505,185 | |
| 232.65 | 236.54 | 231.25 | 233.29 | 1,344,122 | |
| 235.18 | 237.98 | 231.29 | 231.83 | 1,404,860 | |
| 230.00 | 234.30 | 228.12 | 234.03 | 1,257,474 |
Dilution timeline
As of
No filings in the saved snapshot.
Parsed share counts, prices and warrant terms require Plus or above. Explore plans
Research this company
FennEdge organizes SEC filings and reported market data. Sign in for additional research and your private trading context.
Sign in to continue